The daily business briefing: April 28, 2016
Facebook smashes expectations, SpaceX plans flight to Mars, and more

- 1. Facebook stock soars after unexpectedly strong results
- 2. SpaceX unveils plan to send unmanned spacecraft to Mars
- 3. Dow futures plunge after Bank of Japan rejects calls for new stimulus
- 4. Pending home sales rise in latest sign of housing market strength
- 5. Abbott Labs to buy St. Jude Medical for $25 billion

1. Facebook stock soars after unexpectedly strong results
Facebook shares jumped by 8 percent Wednesday after the social networking site reported first quarter revenue that smashed Wall Street's expectations. Facebook's revenue rose to 77 cents per share after adjustments. Analysts had forecast 62 cents per share. Mobile ads accounted for 82 percent of Facebook's ad revenue, up from 73 percent last year. The company also said it would create a new class of non-voting stock that will allow Facebook CEO and co-founder Mark Zuckerberg to maintain control as he fulfills a pledge to donate nearly all of his stock to charity.
MarketWatch The New York Times
2. SpaceX unveils plan to send unmanned spacecraft to Mars
Private rocket builder SpaceX announced Wednesday that it plans to land an unmanned spacecraft on Mars as soon as 2018. The company was founded 10 years ago by billionaire entrepreneur Elon Musk with the aim of colonizing Mars, and has become a leader in private space flight with a waiting list of orders for satellite launches. It said it would make the 140-million-mile trip with help from NASA.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Dow futures plunge after Bank of Japan rejects calls for new stimulus
The Dow Jones Industrial Average futures pointed to a triple-digit, 1 percent loss early Thursday after the Bank of Japan unexpectedly said it was offering no additional stimulus measures. The news sent Japan's Nikkei 225 index plunging by 3.6 percent, its biggest daily loss since February. The turmoil came after U.S. stocks gained on Wednesday when the Federal Reserve announced at the end of its two-day meeting that it was holding U.S. interest rates unchanged for now, but left the door open to a June hike as the U.S. economy improves despite global weakness.
MarketWatch The Associated Press
4. Pending home sales rise in latest sign of housing market strength
Pending sales of previously-owned homes rose in March to their highest level in nearly a year, the National Association of Realtors said on Wednesday. The 1.4 percent sale increase year-over-year beat economists' expectations of a 0.5 percent increase. The data added to recent indications that the housing market is strong, although the National Association of Realtors said prices had climbed so high in the West that demand there has weakened.
5. Abbott Labs to buy St. Jude Medical for $25 billion
Abbott Laboratories has agreed to buy medical device maker St. Jude Medical for $25 billion. The deal amounts to about $85 per share, representing a 37 percent premium on St. Jude's Wednesday closing price. The stock was trading at $79.45 before the market opened Thursday. Abbott said the deal would help boost its offerings of cardiovascular and neurological devices.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
UK-India trade deal: how the social security arrangements will work
The Explainer A National Insurance exemption in the UK-India trade deal is causing concern but should British workers worry?
-
Man arrested after 'suspicious' fires at properties linked to Keir Starmer
Speed Read Prime minister thanks emergency services after fire at his former family home in north London
-
Elon Musk's SpaceX has created a new city in Texas
under the radar Starbase is home to SpaceX's rocket launch site
-
What happens if tensions between India and Pakistan boil over?
TODAY'S BIG QUESTION As the two nuclear-armed neighbors rattle their sabers in the wake of a terrorist attack on the contested Kashmir region, experts worry that the worst might be yet to come
-
Why Russia removed the Taliban's terrorist designation
The Explainer Russia had designated the Taliban as a terrorist group over 20 years ago
-
Inside the Israel-Turkey geopolitical dance across Syria
THE EXPLAINER As Syria struggles in the wake of the Assad regime's collapse, its neighbors are carefully coordinating to avoid potential military confrontations
-
'Like a sound from hell': Serbia and sonic weapons
The Explainer Half a million people sign petition alleging Serbian police used an illegal 'sound cannon' to disrupt anti-government protests
-
The arrest of the Philippines' former president leaves the country's drug war in disarray
In the Spotlight Rodrigo Duterte was arrested by the ICC earlier this month
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
-
Why Serbian protesters set off smoke bombs in parliament
THE EXPLAINER Ongoing anti-corruption protests erupted into full view this week as Serbian protesters threw the country's legislature into chaos
-
Who is the Hat Man? 'Shadow people' and sleep paralysis
In Depth 'Sleep demons' have plagued our dreams throughout the centuries, but the explanation could be medical